Puma Biotechnology Inc PBYI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:02 PM EDT
4.95quote price arrow down-0.12 (-2.47%)
Volume
130,780
52 week range
2.13 - 7.73
Loading...
  • Open5.05
  • Day High5.17
  • Day Low4.90
  • Prev Close5.07
  • 52 Week High7.73
  • 52 Week High Date02/15/24
  • 52 Week Low2.13
  • 52 Week Low Date10/25/23

Key Stats

  • Market Cap238.384M
  • Shares Out48.21M
  • 10 Day Average Volume0.26M
  • Dividend-
  • Dividend Yield-
  • Beta1.30
  • YTD % Change14.2

KEY STATS

  • Open5.05
  • Day High5.17
  • Day Low4.90
  • Prev Close5.07
  • 52 Week High7.73
  • 52 Week High Date02/15/24
  • 52 Week Low2.13
  • 52 Week Low Date10/25/23
  • Market Cap238.384M
  • Shares Out48.21M
  • 10 Day Average Volume0.26M
  • Dividend-
  • Dividend Yield-
  • Beta1.30
  • YTD % Change14.2

RATIOS/PROFITABILITY

  • EPS (TTM)0.45
  • P/E (TTM)10.95
  • Fwd P/E (NTM)22.79
  • EBITDA (TTM)44.784M
  • ROE (TTM)57.54%
  • Revenue (TTM)235.637M
  • Gross Margin (TTM)73.40%
  • Net Margin (TTM)9.16%
  • Debt To Equity (MRQ)186.48%

EVENTS

  • Earnings Date05/02/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Puma Biotechnology Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Puma Biotechnology, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of products to enhance cancer care. The Company's lead product is NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Neratinib is a potent irreversible tyrosine kinase inhibitor (TKI) that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2 and HER4 It also engaged in the development and...
Alan Auerbach
Chairman of the Board, President, Chief Executive Officer, Secretary
Maximo Nougues
Chief Financial Officer
Address
10880 Wilshire Blvd., Suite 2150
Los Angeles, CA
90024
United States

Top Peers

SYMBOLLASTCHG%CHG
ME
23andMe Holding Co.
0.5033+0.0011+0.219%
CHRS
Coherus BioSciences Inc
1.99+0.03+1.28%
RVNC
Revance Therapeutics Inc
3.75+0.14+3.91%
AKBA
Akebia Therapeutics Inc
1.25-0.01-0.40%
PACB
Pacific Biosciences of California Inc
1.64-0.01-0.61%